Skip to main content
Clinical Cardiology logoLink to Clinical Cardiology
. 2007 Sep 6;30(10):498–502. doi: 10.1002/clc.17

Cardiac Resynchronization Therapy and its Potential Proarrhythmic Effect

Indranill Basu Ray 1, Lahn Fendelander 1, Jagmeet P Singh 1,
PMCID: PMC6653034  PMID: 17823906

Abstract

Cardiac resynchronization therapy (CRT) has become an established adjunctive treatment to optimal pharmacologic therapy in patients with advanced chronic heart failure (CHF), diminished left ventricular (LV) function and intraventricular conduction delay. Although CRT has been shown to improve ventricular hemodynamics, quality of life and exercise capacity, there is some evidence that it may rarely potentiate ventricular arrhythmias. As CRT is considered for an expanded population of CHF patients, and left‐sided pacing is considered as an option for pacemaker‐indicated patients (potentially without defibrillator backup), the effect of these pacing modalities on the incidence of ventricular tachyarrhythmia must be systematically studied and mechanistically understood. Strategies to prospectively predict the proarrhythmic potential of LV epicardial pacing need to be developed, and therapy accordingly individualized. This review attempts to summarize the current information on proarrhythmia in resynchronization therapy. Copyright © 2007 Wiley Periodicals, Inc.

Keywords: cardiac resynchronization, proarrhythmia, pacemakers, implantable devices, defibrillators, heart failure, sudden cardiac death

Full Text

The Full Text of this article is available as a PDF (743.4 KB).

References

  • 1. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, et al.: Cardiac resynchronization in chronic heart failure. N Engl J Med 2002; 346(24): 1845–1853. [DOI] [PubMed] [Google Scholar]
  • 2. Auricchio A, Stellbrink C, Butter C, Sack S, Vogt J, et al.: Clinical efficacy of cardiac resynchronization therapy using left ventricular pacing in heart failure patients stratified by severity of ventricular conduction delay. J Am Coll Cardiol 2003; 42(12): 2109–2116. [DOI] [PubMed] [Google Scholar]
  • 3. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, et al.: Cardiac‐resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004; 350(21): 2140–2150. [DOI] [PubMed] [Google Scholar]
  • 4. Walker S, Levy TM, Rex S, Brant S, Allen J, et al.: Usefulness of suppression of ventricular arrhythmia by biventricular pacing in severe congestive cardiac failure. Am J Cardiol 2000; 86(2): 231–233. [DOI] [PubMed] [Google Scholar]
  • 5. Zagrodzky JD, Ramaswamy K, Page RL, Joglar JA, Sheehan CJ, et al.: Biventricular pacing decreases the inducibility of ventricular tachycardia in patients with ischemic cardiomyopathy. Am J Cardiol 2001; 87(10): 1208–1210; A7. [DOI] [PubMed] [Google Scholar]
  • 6. Ermis C, Seutter R, Zhu AX, Benditt LC, VanHeel L, et al.: Impact of upgrade to cardiac resynchronization therapy on ventricular arrhythmia frequency in patients with implantable cardioverter‐defibrillators. J Am Coll Cardiol 2005; 46(12): 2258–2263. [DOI] [PubMed] [Google Scholar]
  • 7. Kies P, Bax JJ, Molhoek SG, Bleeker GB, Zeppenfeld K, et al.: Effect of left ventricular remodeling after cardiac resynchronization therapy on frequency of ventricular arrhythmias. Am J Cardiol 2004; 94(1): 130–132. [DOI] [PubMed] [Google Scholar]
  • 8. Martinelli Filho M, Pedrosa AA, Costa R, Nishioka SA, Siqueira SF, et al.: Biventricular pacing improves clinical behavior and reduces prevalence of ventricular arrhythmia in patients with heart failure. Arq Bras Cardiol 2002; 78(1): 110–113. [DOI] [PubMed] [Google Scholar]
  • 9. Medina‐Ravell VA, Lankipalli RS, Yan GX, Antzelevitch C, Medina‐Malpica NA, et al.: Effect of epicardial or biventricular pacing to prolong QT interval and increase transmural dispersion of repolarization: does resynchronization therapy pose a risk for patients predisposed to long QT or torsade de pointes? Circulation 2003; 107(5): 740–746. [DOI] [PubMed] [Google Scholar]
  • 10. Rivero‐Ayerza M, Vanderheyden M, Verstreken S, de Zutter M, Geelen P, et al.: Images in cardiovascular medicine. Polymorphic ventricular tachycardia induced by left ventricular pacing. Circulation 2004; 109(23): 2924–2925. [DOI] [PubMed] [Google Scholar]
  • 11. Shukla G, Chaudhry GM, Orlov M, Hoffmeister P, Haffajee C: Potential proarrhythmic effect of biventricular pacing: fact or myth? Heart Rhythm 2005; 2(9): 951–956. [DOI] [PubMed] [Google Scholar]
  • 12. Moss AJ, Brown MW, Cannom DS, Daubert JP, Estes M, et al.: Multicenter automatic defibrillator implantation trial‐cardiac resynchronization therapy (MADIT‐CRT): design and clinical protocol. Ann Noninvasive Electrocardiol 2005; 10(suppl 4): 34–43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Achilli A, Sassara M, Ficili S, Pontillo D, Achilli P, et al.: Long‐term effectiveness of cardiac resynchronization therapy in patients with refractory heart failure and “narrow” QRS. J Am Coll Cardiol 2003; 42(12): 2117–2124. [DOI] [PubMed] [Google Scholar]
  • 14. Nelson GS, Berger RD, Fetics BJ, Talbot M, Spinelli JC, et al.: Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle‐branch block. Circulation 2000; 102(25): 3053–3059. [DOI] [PubMed] [Google Scholar]
  • 15. Auricchio A, Stellbrink C, Block M, Sack S, Vogt J, et al.: Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. The Pacing Therapies for Congestive Heart Failure Study Group. The Guidant Congestive Heart Failure Research Group. Circulation 1999; 99(23): 2993–3001. [DOI] [PubMed] [Google Scholar]
  • 16. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, et al.: The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005; 352(15): 1539–1549. [DOI] [PubMed] [Google Scholar]
  • 17. Yu C‐M, Bleeker GB, Fung JW‐H, Schalij MJ, Zhang Q, et al.: Left ventricular reverse remodeling but not clinical improvement predicts long‐term survival after cardiac resynchronization therapy. Circulation 2005; 112(11): 1580–1586. [DOI] [PubMed] [Google Scholar]
  • 18. Hamdan MH, Zagrodzky JD, Joglar JA, Sheehan CJ, Ramaswamy K, et al.: Biventricular pacing decreases sympathetic activity compared with right ventricular pacing in patients with depressed ejection fraction. Circulation 2000; 102(9): 1027–1032. [DOI] [PubMed] [Google Scholar]
  • 19. Adamson PB, Kleckner KJ, VanHout WL, Srinivasan S, Abraham WT: Cardiac resynchronization therapy improves heart rate variability in patients with symptomatic heart failure. Circulation 2003; 108(3): 266–269. [DOI] [PubMed] [Google Scholar]
  • 20. Fantoni C, Raffa S, Regoli F, Giraldi F, La Rovere MT, et al.: Cardiac resynchronization therapy improves heart rate profile and heart rate variability of patients with moderate to severe heart failure. J Am Coll Cardiol 2005; 46(10): 1875–1882. [DOI] [PubMed] [Google Scholar]
  • 21. Carson P, Anand I, O'Connor C, Jaski B, Steinberg J, et al.: Mode of death in advanced heart failure the Comparison of Medical, Pacing, and Defibrillation Therapies in Heart Failure (COMPANION) Trial. J Am Coll Cardiol 2005; 46(12): 2329–2334. [DOI] [PubMed] [Google Scholar]
  • 22. Daubert JC, Leclercq C, Mabo P: There is plenty of room for cardiac resynchronization therapy devices without back‐up defibrillators in the electrical treatment of heart failure. J Am Coll Cardiol 2005; 46(12): 2204–2207. [DOI] [PubMed] [Google Scholar]
  • 23. McAlister FA, Ezekowitz JA, Wiebe N, Rowe B, Spooner C, et al.: Systematic review: cardiac resynchronization in patients with symptomatic heart failure. Ann Intern Med 2004; 141(5): 381–390. [DOI] [PubMed] [Google Scholar]
  • 24. Bradley DJ, Bradley EA, Baughman KL, Berger RD, Calkins H, et al.: Cardiac resynchronization and death from progressive heart failure: A meta‐analysis of randomized controlled trials. JAMA 2003; 289(6): 730–740. [DOI] [PubMed] [Google Scholar]
  • 25. Fish JM, Di Diego JM, Nesterenko V, Antzelevitch C: Epicardial activation of left ventricular wall prolongs QT interval and transmural dispersion of repolarization: Implications for biventricular pacing. Circulation 2004; 109(17): 2136–2142. [DOI] [PubMed] [Google Scholar]
  • 26. Akar FG, Rosenbaum DS: Transmural electrophysiological heterogeneities underlying arrhythmogenesis in heart failure. Circ Res 2003; 93(7): 638–645. [DOI] [PubMed] [Google Scholar]
  • 27. Antzelevitch C, Sicouri S, Litovsky SH, Lukas A, Krishnan SC, et al.: Heterogeneity within the ventricular wall. Electrophysiology and pharmacology of epicardial, endocardial, and M cells. Circ Res 1991; 69(6): 1427–1449. [DOI] [PubMed] [Google Scholar]
  • 28. Yan G‐X, Rials SJ, Wu Y, Liu T, Xu X, et al.: Ventricular hypertrophy amplifies transmural repolarization dispersion and induces early afterdepolarization. Am J Physiol Heart Circ Physiol 2001; 281(5): H1968–H1975. [DOI] [PubMed] [Google Scholar]
  • 29. Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, et al.: The Multisite Stimulation in Cardiomyopathies Study I. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001; 344(12): 873–880. [DOI] [PubMed] [Google Scholar]
  • 30. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, et al.: Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346(12): 877–883. [DOI] [PubMed] [Google Scholar]
  • 31. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, et al.: Amiodarone or an implantable cardioverter‐defibrillator for congestive heart failure. N Engl J Med 2005; 352(3): 225–237. [DOI] [PubMed] [Google Scholar]
  • 32. Garrigue S, Barold SS, Hocini M, Jais P, Haissaguerre M, et al.: Treatment of drug refractory ventricular tachycardia by biventricular pacing. Pacing Clin Electrophysiol 2000; 23(11): 1700–1702. [DOI] [PubMed] [Google Scholar]
  • 33. Roden DM: A surprising new arrhythmia mechanism in heart failure. Circ Res 2003; 93(7): 589–591. [DOI] [PubMed] [Google Scholar]
  • 34. Bloomfield DM, Steinman RC, Namerow PB, Parides M, Davidenko J, et al.: Microvolt t‐wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: A solution to the multicenter automatic defibrillator implantation trial (MADIT) II conundrum. Circulation 2004; 110(14): 1885–1889. [DOI] [PubMed] [Google Scholar]
  • 35. Zabel M, Portnoy S, Franz MR: Electrocardiographic indexes of dispersion of ventricular repolarization: An isolated heart validation study. J Am Coll Cardiol 1995; 25(3): 746–752. [DOI] [PubMed] [Google Scholar]
  • 36. Puggioni E, Brignole M, Gammage M, Soldati E, Bongiorni MG, et al.: Acute comparative effect of right and left ventricular pacing in patients with permanent atrial fibrillation. J Am Coll Cardiol 2004; 43(2): 234–238. [DOI] [PubMed] [Google Scholar]
  • 37. Fish JM, Brugada J, Antzelevitch C: Potential proarrhythmic effects of biventricular pacing. J Am Coll Cardiol 2005; 46(12): 2340–2347. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical Cardiology are provided here courtesy of Wiley

RESOURCES